Trabectedin as a Single-Agent Treatment of Advanced Breast Cancer After Anthracycline and Taxane Treatment: A Multicenter, Randomized, Phase II Study Comparing 2 Administration Regimens-Reference-Cited by-同舟云学术

Trabectedin as a Single-Agent Treatment of Advanced Breast Cancer After Anthracycline and Taxane Treatment: A Multicenter, Randomized, Phase II Study Comparing 2 Administration Regimens

Published:2014-12 Issue:6 Volume:14 Page:396-404
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Goldstein Lori J.,Gurtler Jayne,Del Prete Salvatore A.,Tjulandin Sergei,Semiglazov Vladimir F.,Bayever Eliel,Michiels Bart

Funder

Janssen Research & Development, LLC

PharmaMar

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. American Cancer Society. Cancer Facts & Figures 2014. Available at: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf. Accessed June 16, 2014.

2. Yondelis (trabectedin, ET-743): the development of an anticancer agent of marine origin;van Kesteren;Anticancer Drugs,2003

3. Mechanism for the catalytic activation of ecteinasacidin 743 and its subsequent alkylation of guanine N2;Moore;J Am Chem Soc,1998

4. Ecteinascidin-743: a minor groove alkylator that bends DNA towards the major groove;Zewail-Foote;J Med Chem,1999

5. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by Ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata;Pommier;Biochemistry,1996

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on current and new potential immunotherapies in breast cancer, from bench to bedside;Frontiers in Immunology;2024-02-15

2. Recent advances in BCRP‐induced breast cancer resistance treatment with marine‐based natural products;IUBMB Life;2023-07-13

3. From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds;Frontiers in Pharmacology;2022-09-08

4. Trabectedin in Cancers: Mechanisms and Clinical Applications;Current Pharmaceutical Design;2022-07

5. Epigenetic based synthetic lethal strategies in human cancers;Biomarker Research;2020-09-15